American Portfolios Advisors’s CureVac CVAC Stock Holding History

American Portfolios Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100	Closed	-$9.15K	–	3406
2021 Q1	$9.15K	Buy	+100	New	+$9.7K	﹤0.01%	2419

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

American Portfolios Advisors's CVAC Position: Q2 2021 in Review

American Portfolios Advisors sold out of CureVac (CVAC) in Q2 2021, closing a stake of 100 shares — an estimated $9.15K sold.

American Portfolios Advisors first reported a position in CVAC in Q1 2021 and held it in 1 quarter. The position peaked at $9.15K in Q1 2021. 109 funds tracked by Wall St. Rank hold CVAC as of Q2 2021.

American Portfolios Advisors reported no remaining CureVac position as of Q2 2021 after selling out during the quarter.
American Portfolios Advisors sold 100 CureVac shares in Q2 2021, an estimated $9.15K.
American Portfolios Advisors first reported a position in CureVac in Q1 2021 and held it in 1 quarter.
American Portfolios Advisors's CureVac position peaked at $9.15K in Q1 2021.
109 funds tracked by Wall St. Rank held CureVac as of Q2 2021.

Based on American Portfolios Advisors's 13F filing for Q2 2021, filed 22 Mar 2023.